Insights Search

On August 10, 2021, the United States Court of Appeals for the Second Circuit (the “Second Circuit”) once again drew on principles of international comity to dismiss antitrust price-fixing claims against Chinese vitamin C manufacturers.

On July 30, 2021, Securities and Exchange Commission (“SEC”) Chair Gary Gensler issued a public statement announcing that he has asked SEC staff to require additional disclosures from offshore issuers with ties to China-based operating companies.

Earlier this month, DOJ released a superseding indictment in its federal case against one of the world’s largest telecommunications corporations, Huawei Technologies Co., Ltd. (“Huawei”), in the Eastern District of New York (“EDNY”).